Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...

Sleep disturbances are common in old age, but drastic changes, such as waking up at 3 am or not being able to stay awake ...

Health experts have warned people to be vigilant of the early signs of dementia, which include inconspicuous issues like ...

A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...

Advanced artificial intelligence genetics models have been successfully applied to Parkinson’s disease at CCGC.

New research from The Feinstein Institutes for Medical Research reveals that brain imaging can detect subtle abnormalities in ...

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, a new study indicates.

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, and will now pause its development.

Now, researchers have identified ... Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson's Disease Sep. 18, 2024 — A class of drugs for diabetes may be associated with a lower risk of ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...